Islet allografts are subject to alloimmune and autoimmune destruction when transplanted into autoimmune prone animals or humans. The ICOS-B7h pathway plays a role in alloimmune responses, but its function in autoimmunity against islet cells is controversial. We investigated the role of ICOS signaling in autoimmune and alloimmune responses in NOD mice. ICOS blockade prevents development of spontaneous disease in pre-diabetic NOD mice. Furthermore, while ICOS blockade prolongs graft survival in a fully mismatched non-autoimmune islet allograft model in C57BL/6 recipients, it has no beneficial effect in reversing diabetes in models of islet transplantation in NOD mice involving autoimmunity alone or both allo- and autoimmunity. Interestingly, ICOS blockade is effective in prolonging heart allograft (not subject to tissue-specific autoimmunity) survival in NOD mice. We conclude that in islet transplantation and autoimmune diabetes, ICOS blockade can be effective in inhibiting alloimmunity and preventing autoimmunity but is ineffective in inhibiting recurrence of autoimmunity.

Role of ICOS pathway in autoimmune and alloimmune responses in NOD mice / M.J.I. Ansari, P. Fiorina, S. Dada, I. Guleria, T. Ueno, X. Yuan, S. Trikudanathan, R.N. Smith, G. Freeman, M.H. Sayegh. - In: CLINICAL IMMUNOLOGY. - ISSN 1521-6616. - 126:2(2008), pp. 140-147.

Role of ICOS pathway in autoimmune and alloimmune responses in NOD mice

P. Fiorina
Secondo
;
2008

Abstract

Islet allografts are subject to alloimmune and autoimmune destruction when transplanted into autoimmune prone animals or humans. The ICOS-B7h pathway plays a role in alloimmune responses, but its function in autoimmunity against islet cells is controversial. We investigated the role of ICOS signaling in autoimmune and alloimmune responses in NOD mice. ICOS blockade prevents development of spontaneous disease in pre-diabetic NOD mice. Furthermore, while ICOS blockade prolongs graft survival in a fully mismatched non-autoimmune islet allograft model in C57BL/6 recipients, it has no beneficial effect in reversing diabetes in models of islet transplantation in NOD mice involving autoimmunity alone or both allo- and autoimmunity. Interestingly, ICOS blockade is effective in prolonging heart allograft (not subject to tissue-specific autoimmunity) survival in NOD mice. We conclude that in islet transplantation and autoimmune diabetes, ICOS blockade can be effective in inhibiting alloimmunity and preventing autoimmunity but is ineffective in inhibiting recurrence of autoimmunity.
Autoimmune diabetes; Costimulation; ICOS; Islet transplantation; NOD mice; Sirolimus; Animals; Antibodies, Monoclonal; Antigens, Differentiation, T-Lymphocyte; Autoimmunity; Diabetes Mellitus, Type 1; Graft Rejection; Graft Survival; Heart Transplantation; Immunologic Factors; Immunosuppressive Agents; Inducible T-Cell Co-Stimulator Protein; Islets of Langerhans; Islets of Langerhans Transplantation; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred NOD; Signal Transduction; Sirolimus; Immunology; Immunology and Allergy
Settore MED/13 - Endocrinologia
2008
Article (author)
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S1521661607012788-main.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 1.68 MB
Formato Adobe PDF
1.68 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/499321
Citazioni
  • ???jsp.display-item.citation.pmc??? 27
  • Scopus 49
  • ???jsp.display-item.citation.isi??? 48
social impact